Making West Pharmaceutical Pick #5 in my Special Report 10 New Ideas for an Old Rally
Here’s what I wrote today when I added this stock to my Special Report.
WST
Special Report: “10 New Stock Ideas for an Old Rally”–first 5 picks
The Standard & Poor’s 500 Index had a banner first half of 2024 with the index climbing more than 17% as of June 30. But two-thirds of that gain is attributable to just six stocks: Nvidia (NVDA), Microsoft (MSFT), Alphabet (GOOG), Amazon.com (AMZN), Meta Platforms (META), and Apple (AAPL.).Track the performance of equal-weighted version of the S&P 500–rather than the commonly tracked index where the contribution of any stock to the index is weighted by market cap–and the index was up just 3.9% in the first half of 2024. For the second half of 2024 and looking ahead to 2024, I’m not so much worried about the fundamentals of this extraordinary rally as I am by a failure of market imagination Everybody owns the same 6 stocks. Hey, I get the excitement around these stocks and the boom in Artificial Intelligence. I share it. Which is why I own shares of Nvidia, Amazon, and Alphabet in my online portfolios. But there are 494 other stocks in the S&P 500. And 2000 stocks in the small-cap Russell 2000.(Up 9% in the first half of 2024.)After a rally that has recorded 30 new record highs for the S&P 500 just the first half of n 2024, some of that other 494–or 2000–are actually better stock buys, and likely to out perform the 6 stocks everybody owns from their current record high prices. But which ones? That’s what my Special Report: “10 New Stock Ideas for an Old Rally” is all about.
I’m making West Pharmaceutical Services pick No. 9 in my Special Report: 10 Greatest Savings Account Stocks
It’s been a while but I haven’t forgotten. Back on October 5 I named Intuit (INTU) my eighth pick in my Special Report: 10 Greatest “Savings Account Stocks. Which meant that I owned readers two more picks. Today’s pick of West Pharmaceutical Services (WST) is pick No.9. One more to go. (As with picks No. 7 MasterCard and No. 8 Intuit, I’m suggesting that you hold off on buying West Pharmaceutical until we see a bigger dip or what I now anticipate as the end of the current extreme volatility sometime around March 2022.)
Watch my YouTube video: 4 Picks for the Omicron Wave
I’m starting up my videos on JubakAM.com again–this time using YouTube as a platform. My seventy-fifth YouTube video “4 Picks for the Omicron Wave” went up today.
Special Report: Profit and Protect–What you need to know about stock market stages for 2021–Stage 2 of 3: My rules for selling in the “When you win, you lose market” (and sells of ILMN, CTVA, WST, and VMW)
On to Stage #2 in my Special Report: “Profit and Protect–What you need to know about stock market stages for 2021. And to my rules for the sells and hedges in Stage #2 for 2021: When you win, you lose. (I just posted sells for ILMN, CTVA, WST and VMW)
Adding West Pharmaceutical Services to Jubak Picks Portfolio on rotation back to momentum winners
What a difference 72 hours can make. Just a few days ago I was looking to find consumer/cyclical/"re-opening dependent" shares as the stock market looked to be rotating away from recent technology and momentum leaders and toward beaten down shares that would climb...
West Pharmaceutical beats on earnings, revenue, and climbs 10.17% on April 23
West Pharmaceutical (WST) reported first quarter earnings of $1.01 a share on Thursday, April 23. That beat Wall Street estimates by 19 cents a share and was up 36% year over year. Revenue of $491 million for the quarter was up 10.8% year over year and exceeded Wall...
5 MORE smart, short-term moves while we wait for longer-term trends to resolve
In my recent post "What do you do when the market is insane and you're not?" I argued that one of the dangers in a very volatile market with strong--and temporarily profitable--short-term trends is that we'll give in to the pressure to do something--and do something...
#3 of my four “Not so easy pieces” for rebalancing my long-term 50 Stocks Portfolio: My four buys
In my most recent Special Report: When to sell: What to sell I recommended that any current rebalancing build up some cash. To implement that cash-building strategy, when you sell to rebalance a portfolio for 2020, buy fewer stocks than you sell so that the result is...
U.S. stocks roar back this afternoon–what’s that all about?
U.S. stocks after being deep in the red this morning, came roaring back this afternoon. Or at least technology shares did. The Standard and Poor's 500, which had been as low as 2583 today, climbed back to close at 2637. The swing from high of the day to low was a huge...
Special Report: My 10 small company stock picks for the January Effect rally
Two robins don't make a spring. And two bounces--even when one of them is a really big bounce like that of Wednesday November 28--don't make a January Effect Rally in small company stocks. But it sure looks to me like the sector is setting up for a typical January...Jim’s Stock Alerts
Download Jim’s eBook for Free
